Defining how pancreatic cancer cells respond/resist a new type of targeted treatment
Review a project summary that will investigate how a new class of drugs work against pancreatic cancer.
The project
There are no current treatments for pancreatic cancer patients that aim to target cancer cells without affecting normal cells. Being able to do so would help treat patients effectively whilst reducing side effects.
Dr Victoria Hart from the University of Sheffield is investigating how a new class of drugs work against pancreatic cancer. These drugs are designed to selectively target the cancer cells, potentially treating the patient more effectively whilst reducing side effects. She would like to define exactly how pancreatic cancer cells respond or resist these new drugs. By developing this understanding just as these drugs enter clinical trials, she can anticipate the development of resistance and offer solutions, such as potential co-treatments or biomarkers to identify the patients most likely to benefit.
She is applying for a Pancreatic Cancer UK Career Foundation Fellowship grant and would like you to read a project summary of her project to get feedback.
Next steps
No scientific background or prior experience is needed to take part in this opportunity.
If you would like to give your feedback on this project, please contact the Research Team (research@pancreaticcancer.org.uk) quoting the involvement reference ‘Hart’. We will then email you the lay summary and specific questions Dr Victoria Hart would like you to consider. Please return your responses to the research team by Sunday 17th November 2024.
